Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Contineum Therapeutics Inc increased its cash reserves by 178.79%, or 9.96m. Cash Flow from Financing totalled 56.18m or 112.35% of revenues. In addition the company generated 19.35m in cash from operations while cash used for investing totalled 65.57m.
Cash flow per share | -1.24 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 8.46 |
---|---|
Tangible book value per share | 8.46 |
More ▼
Balance sheet in USDView more
Current ratio | 58.92 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼